We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWS:NASDAQNews Corporation Analysis

Data as of 2026-04-21 - not real-time

$30.35

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

News Corporation is trading around $30, just below the recent resistance level and comfortably above the identified support zone. The 20‑day and 50‑day moving averages sit beneath the current price, indicating a modest upward bias, while the RSI is perched in the overbought territory, suggesting short‑term pressure. MACD remains bullish, offering a counterpoint to the overbought signal. The market’s sentiment index shows “Extreme Greed,” which can fuel further buying but also increase the chance of a pullback. The stock’s beta of roughly 0.6 points to lower volatility relative to the broader market, and the 30‑day volatility of about 19% is moderate for the sector.
Fundamentally, revenue is growing at a healthy 5‑6% and margins are solid, with operating and profit margins above 13%. The forward P/E of 24 is still elevated compared with the industry average of 19, yet the discounted cash‑flow model implies a fair value near $52, indicating significant upside. Cash flow generation comfortably covers debt, and the modest payout ratio leaves ample room to sustain the 0.7% dividend. Given the decreasing volume trend, investors should watch for signs of waning buying interest. Overall, the company appears undervalued, with a blend of growth and value characteristics, and the dividend looks sustainable.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought zone
  • Bullish MACD but neutral trend
  • Decreasing volume indicating possible short‑term weakness

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value substantially above market price
  • Steady revenue growth and solid margins
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervalued relative to intrinsic value
  • Diversified global operations reducing geographic concentration
  • Strong cash flow generation supporting debt coverage and dividend

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin13.35%
P/E Ratio39.4
ROE6.33%
ROA3.94%
Debt/Equity30.89
P/B Ratio1.9
Op. Cash Flow$1.1B
Free Cash Flow$1.7B
Industry P/E19.2

Technical Analysis

TrendNeutral
RSI75.0
Support$26.87
Resistance$30.48
MA 20$28.58
MA 50$27.49
MA 200$30.45
MACDBullish
VolumeDecreasing
Fear & Greed Index86.66

Valuation

Fair Value$52.40
GradeUndervalued
TypeBlend
Dividend Yield0.67%

Risk Assessment

Beta0.60
Volatility18.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.